US Stem Cell Inc (USRM)

[Xpecht]

The lawsuit nonsense IMO is an opportunity to accumulate more cheap shares. With revenues increasing quarter after quarter coupled with the demand in this space,it’s just a matter of time here. IMO there will be a major partnership announced in 2018, a company that has the $$$ to bring this to the next level. As demand for stem cell treatments increases daily and people are educated on this medical technology, some big company will see that as an opportunity to capitalize on. In fact we saw this with The potential 5 Million investment earlier this year until the FDA pulled the rug out from the RMAT with the lack of a clear path. Since then the path to RMAT is more clear, the FDA seems to be more open to this space as a major healthcare solution, and USRM announced RMAT is still in play and partnerships are being explored. IMO everything is setting up nicely. Those of us that have been here a while know that when it runs it runs fast and it’s hard to get shares. Enjoy these times as long as Time is on your side of course.